Long-lasting anticryptosporidial activity of nitazoxanide in an immunosuppressed rat model

被引:42
作者
Li, X
Brasseur, P
Agnamey, P
Leméteil, D
Favennec, L
Ballet, JJ [1 ]
Rossignol, JF
机构
[1] CHU Clemenceau, Lab Immunol & Immunopathol, F-14033 Caen, France
[2] Fac Med Pharm, Parasitol Lab, F-76138 Rouen, France
[3] ADEN, UPRES EA 3234, F-76138 Rouen, France
[4] Univ London London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1E 7HT, England
关键词
Cryptosporidium parvum; nitazoxanide; immunosuppressed rat model;
D O I
10.14411/fp.2003.003
中图分类号
R38 [医学寄生虫学]; Q [生物科学];
学科分类号
07 ; 0710 ; 09 ; 100103 ;
摘要
Cryptosporidium parvum, Tyzzer, 1912 is identified as a common cause of diarrhoea in immunocompetent individuals. In immunocompromised, especially HIV-infected subjects, cryptosporidiosis causes severe chronic diarrhoea. In this study, nitazoxanide (NTZ) was compared for curative activity with sinefungin (SNF) and paromomycin (PRM) in immunosuppressed rats, a screening model for anticryptosporidial agents. NTZ at either 50 mg/kg/day, 100 mg/kg/day or 200 mg/kg/day resulted in seven days in a dose-dependent inhibition of oocyst shedding similar to that obtained with SNF (10 mg/kg/day) and PRM (100 mg/kg/day). Further discontinuation of SNF or PRM 100 mg/kg/day therapy resulted in early relapse of oocyst shedding which reached the pre-treatment levels in 2-4 days. In contrast, seven days after discontinuation of therapy, shedding inhibition was unchanged in NTZ-treated rats. Data prompt further assessment of the activity of NTZ on sequestered C. parvum.
引用
收藏
页码:19 / 22
页数:4
相关论文
共 23 条
  • [1] Successful treatment with nitazoxanide of Enterocytozoon bieneusi microsporidiosis in a patient with AIDS
    Bicart-Sée, A
    Massip, P
    Linas, MD
    Datry, A
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (01) : 167 - 168
  • [2] Comparative efficacy evaluation of dicationic carbazole compounds, nitazoxanide, and paromomycin against Cryptosporidium parvum infections in a neonatal mouse model
    Blagburn, BL
    Drain, KL
    Land, TM
    Kinard, RG
    Moore, PH
    Lindsay, DS
    Patrick, DA
    Boykin, DW
    Tidwell, RR
    [J]. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1998, 42 (11) : 2877 - 2882
  • [3] BLAGBURN BL, 1997, CRYPTOSPORIDIUM CRYP, P111
  • [4] RAT MODEL FOR HUMAN CRYPTOSPORIDIOSIS
    BRASSEUR, P
    LEMETEIL, D
    BALLET, JJ
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1988, 26 (05) : 1037 - 1039
  • [5] BRASSEUR P, 1994, FOLIA PARASIT, V41, P13
  • [6] Davies L, 2000, POETRY WALES, V36, P50
  • [7] Nitazoxanide in the treatment of cryptosporidial diarrhea and other intestinal parasitic infections associated with acquired immunodeficiency syndrome in tropical Africa
    Doumbo, O
    Rossignol, JF
    Pichard, E
    Traore, HA
    Dembele, M
    Diakite, M
    Traore, F
    Diallo, DA
    [J]. AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1997, 56 (06) : 637 - 639
  • [8] DUBREUIL L, 1996, ANTIMICROB AGENTS CH, V40, P2260
  • [9] Human cryptosporidiosis: Epidemiology, transmission, clinical disease, treatment, and diagnosis
    Griffiths, JK
    [J]. ADVANCES IN PARASITOLOGY - OPPORTUNISTIC PROTOZOA IN HUMANS, 1998, 40 : 37 - 85
  • [10] THERAPEUTIC EFFICACY OF PAROMOMYCIN IN IMMUNOSUPPRESSED ADULT MICE INFECTED WITH CRYPTOSPORIDIUM-PARVUM
    HEALEY, MC
    YANG, SG
    RASMUSSEN, KR
    JACKSON, MK
    DU, CW
    [J]. JOURNAL OF PARASITOLOGY, 1995, 81 (01) : 114 - 116